Celgene Corp (NASDAQ:CELG)
A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Recs
huddaman
(69.61)
Submitted: 5/16/2013 1:54:58 PM :
Start Price:
$124.47
CELG Score:
-0.20
There is expectation of ~20% annual growth in EPS over the next 3 years. The stock is expensive but probably worth it.
Plus how can you bet against a cancer drugmaker?
Recs
JohnStuartMill
(61.18)
Submitted: 5/14/2013 8:48:19 PM :
Start Price:
$119.66
CELG Score:
-0.44
Positioned well for growth with its cash hoard ($3.5B if you include short term investments, $1.5B if you don't) ready to scoop up bargains. Additional growth drivers include Apremilast, Pomalyst, and Abraxane. I like to call this the apa factor.
Revlimid is kind a bad word here from the European application withdrawal, but that doesn't mean the sales for Revlimid will not increase. They will.
Recs
NoblyNaive
(84.60)
Submitted: 4/23/2013 11:14:27 AM :
Start Price:
$126.53
CELG Score:
-7.19
Excellent ride in March-April 2013. Time to do it again!
High P/E; but Cramer's pitch on a small group of biotechs (REGN, BIIB, GILD, CELG) sold me, the first time I bought in.
April 23, 2013 update: price action continues to be unstoppable. Going with Justin Mamis' advice: Ride a strong trend until price action has a failure." No failure, so far.
Recs
Jim576
(< 20)
Submitted: 4/16/2013 10:56:18 PM :
Start Price:
$121.44
CELG Score:
-4.05
Portfolio strength
Recs
cooleyly
(29.45)
Submitted: 4/12/2013 2:43:20 PM :
Start Price:
$122.67
CELG Score:
-3.61
Great pharma company. Great balance sheet. Explosive growth. Patents good for many years.
Recs
Jonock
(< 20)
Submitted: 4/10/2013 11:11:23 AM :
Start Price:
$119.55
CELG Score:
-1.05
IBD stock on the move
Recs
Recs
giantjimmy
(< 20)
Submitted: 4/8/2013 5:06:12 PM :
Start Price:
$115.93
CELG Score:
+0.69
Remarkable pipeline of new drugs coming over the next four years.
Recs
Recs
ElRemaro
(95.24)
Submitted: 3/31/2013 9:57:15 AM :
Start Price:
$116.51
CELG Score:
+0.46
TMFUltraLong
Recs
Coralreefer1
(< 20)
Submitted: 3/15/2013 9:31:57 AM :
Start Price:
$114.21
CELG Score:
+2.01
Great biopharmaceutical company with all its ducks in a row
Recs
TiptreeTwo
(65.71)
Submitted: 3/5/2013 3:18:32 PM :
Start Price:
$107.96
CELG Score:
+7.27
Sweet spot in oncological drugs, great pipeline, lots of time on patents.
Recs
berdelle
(44.14)
Submitted: 2/12/2013 1:14:09 PM :
Start Price:
$98.99
CELG Score:
+16.11
It's an outstanding company with strong proven products and strong R&D. New potential cancer-fighting products in the pipeline look very promising.
Recs
HILL6BILLY
(20.65)
Submitted: 2/2/2013 8:31:41 AM :
Start Price:
$100.05
CELG Score:
+13.51
Creative and successful biotech attaching cancer.
Recs
ajcmr3
(92.22)
Submitted: 1/29/2013 7:33:59 PM :
Start Price:
$99.00
CELG Score:
+15.06
Strong story driven by Revlimid and Abraxane
Recs
Marmadukemark
(63.96)
Submitted: 1/26/2013 3:40:01 PM :
Start Price:
$99.00
CELG Score:
+14.80
It has several primary products that adding to hight profits, and several in its pipeline are promising in that respect.
Recs
paek813
(96.70)
Submitted: 1/2/2013 2:02:28 PM :
Start Price:
$80.63
CELG Score:
+39.14
S&P: Search Criteria:
S&P STARS Ranking: = 5 stars (5 is the highest rank out of 5)
+
S&P Fair Value Ranking: = 5 (5 = undervalued, 1 = overvalued)
Recs
ptanabe
(63.61)
Submitted: 1/1/2013 1:07:05 AM :
Start Price:
$80.12
CELG Score:
+40.30
many triggers on the horizion
Recs
TMFHelical
(99.03)
Submitted: 11/13/2012 9:54:12 AM :
Start Price:
$75.41
CELG Score:
+44.43
One of the leaders of an annual industry audit that looks at value creation in the biotech space.
http://caps.fool.com/Blogs/a-look-at-established-biotech/774287
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 225 : 1 2 3 4 5 6 7 8 9 10 Next »